A Study to Assess Safety and Efficacy of Avalglucosidase Alfa Administered Every Other Week in Pediatric Patients With Infantile-onset Pompe Disease Previously Treated With Alglucosidase Alfa

Clinical trial NCT03019406 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT03019406

Sponsor

Genzyme, a Sanofi Company

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2017-10-12

Primary completion

2019-09-30

Enrollment

22

View on ClinicalTrials.gov